Literature DB >> 34854540

Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer's disease.

SpiroAnthony Stathas1,2, Victor E Alvarez1,2,3,4, Weiming Xia1,2, Raymond Nicks1,2, Gaoyuan Meng1,2,4, Sarah Daley1,2, Morgan Pothast1, Arsal Shah1,4, Hunter Kelley1, Camille Esnault1, Robert McCormack1, Erin Dixon1, Lucas Fishbein1, Jonathan D Cherry1,3,4, Bertrand R Huber1,3,4, Yorghos Tripodis1,5, Michael L Alosco1,3, Jesse Mez1,3, Ann C McKee1,2,3,4,6, Thor D Stein1,2,3,4,6.   

Abstract

INTRODUCTION: Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy associated with repetitive head impacts (RHI) typically sustained by contact sport athletes. Post-translation modifications to tau in CTE have not been well delineated or compared to Alzheimer's disease (AD).
METHODS: We measured phosphorylated tau epitopes within dorsolateral frontal cortex from post mortem brains with neither CTE nor AD (n = 108), CTE (n = 109), AD (n = 223), and both CTE and AD (n = 33).
RESULTS: Levels of hyperphosphorylated tau (p-tau)202 , p-tau231 , and p-tau396 were significantly increased in CTE. Total years of RHI exposure was significantly associated with increased p-tau202 levels (P = .001), but not p-tau396 . Instead, p-tau396 was most closely related to amyloid beta (Aβ)1-42 levels (P < .001). The p-tau202 :p-tau396 ratio was significantly increased in early and late CTE compared to AD. DISCUSSION: In frontal cortex, p-tau202 is the most upregulated p-tau species in CTE, while p-tau396 is most increased in AD. p-tau202 and p-tau396 measurements may aid in developing biomarkers for disease.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; amyloid beta peptides; brain; chronic traumatic encephalopathy; football; humans; male; microtubule-associated proteins; pathology; statistics and numerical data; tau proteins; tauopathies

Mesh:

Substances:

Year:  2021        PMID: 34854540      PMCID: PMC9160206          DOI: 10.1002/alz.12502

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  60 in total

1.  Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly.

Authors:  D B Evans; K B Rank; K Bhattacharya; D R Thomsen; M E Gurney; S K Sharma
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

2.  Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation.

Authors:  Fei Liu; Bin Li; E-Jan Tung; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Eur J Neurosci       Date:  2007-12-04       Impact factor: 3.386

3.  Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank.

Authors:  Kevin F Bieniek; Owen A Ross; Kerry A Cormier; Ronald L Walton; Alexandra Soto-Ortolaza; Amelia E Johnston; Pamela DeSaro; Kevin B Boylan; Neill R Graff-Radford; Zbigniew K Wszolek; Rosa Rademakers; Bradley F Boeve; Ann C McKee; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-10-30       Impact factor: 17.088

4.  Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

Authors:  G T Bramblett; M Goedert; R Jakes; S E Merrick; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1993-06       Impact factor: 17.173

5.  Cumulative Head Impact Exposure Predicts Later-Life Depression, Apathy, Executive Dysfunction, and Cognitive Impairment in Former High School and College Football Players.

Authors:  Philip H Montenigro; Michael L Alosco; Brett M Martin; Daniel H Daneshvar; Jesse Mez; Christine E Chaisson; Christopher J Nowinski; Rhoda Au; Ann C McKee; Robert C Cantu; Michael D McClean; Robert A Stern; Yorghos Tripodis
Journal:  J Neurotrauma       Date:  2016-06-15       Impact factor: 5.269

6.  Characterization of Early Pathological Tau Conformations and Phosphorylation in Chronic Traumatic Encephalopathy.

Authors:  Nicholas M Kanaan; Kristine Cox; Victor E Alvarez; Thor D Stein; Sharra Poncil; Ann C McKee
Journal:  J Neuropathol Exp Neurol       Date:  2016-01       Impact factor: 3.685

7.  Clinical Utility of Select Neuropsychological Assessment Battery Tests in Predicting Functional Abilities in Dementia.

Authors:  Lee Ashendorf; Michael L Alosco; Hanaan Bing-Canar; Kimberly R Chapman; Brett Martin; Christine E Chaisson; Diane Dixon; Eric G Steinberg; Yorghos Tripodis; Neil W Kowall; Robert A Stern
Journal:  Arch Clin Neuropsychol       Date:  2018-08-01       Impact factor: 2.813

8.  Cortical degeneration in chronic traumatic encephalopathy and Alzheimer's disease neuropathologic change.

Authors:  Richard A Armstrong; Ann C McKee; Thor D Stein; Victor E Alvarez; Nigel J Cairns
Journal:  Neurol Sci       Date:  2018-12-18       Impact factor: 3.307

9.  Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Thomas Arzberger; Safa Al-Sarraj; Istvan Bodi; Nenad Bogdanovic; Heiko Braak; Orso Bugiani; Kelly Del-Tredici; Isidro Ferrer; Ellen Gelpi; Giorgio Giaccone; Manuel B Graeber; Paul Ince; Wouter Kamphorst; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; Sergey Larionov; David Meyronet; Camelia Monoranu; Piero Parchi; Efstratios Patsouris; Wolfgang Roggendorf; Danielle Seilhean; Fabrizio Tagliavini; Christine Stadelmann; Nathalie Streichenberger; Dietmar R Thal; Stephen B Wharton; Hans Kretzschmar
Journal:  Brain Pathol       Date:  2008-03-26       Impact factor: 6.508

10.  The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy.

Authors:  Kevin F Bieniek; Nigel J Cairns; John F Crary; Dennis W Dickson; Rebecca D Folkerth; C Dirk Keene; Irene Litvan; Daniel P Perl; Thor D Stein; Jean-Paul Vonsattel; William Stewart; Kristen Dams-O'Connor; Wayne A Gordon; Yorghos Tripodis; Victor E Alvarez; Jesse Mez; Michael L Alosco; Ann C McKee
Journal:  J Neuropathol Exp Neurol       Date:  2021-02-22       Impact factor: 3.148

View more
  3 in total

1.  A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease.

Authors:  Katherine W Turk; Alexandra Geada; Victor E Alvarez; Weiming Xia; Jonathan D Cherry; Raymond Nicks; Gaoyuan Meng; Sarah Daley; Yorghos Tripodis; Bertrand R Huber; Andrew E Budson; Brigid Dwyer; Neil W Kowall; Robert C Cantu; Lee E Goldstein; Douglas I Katz; Robert A Stern; Michael L Alosco; Jesse Mez; Ann C McKee; Thor D Stein
Journal:  Alzheimers Res Ther       Date:  2022-02-09       Impact factor: 6.982

2.  miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.

Authors:  Long Wang; Xindong Shui; Yingxue Mei; Yongfang Xia; Guihua Lan; Li Hu; Mi Zhang; Chen-Ling Gan; Ruomeng Li; Yuan Tian; Quling Wang; Xi Gu; Dongmei Chen; Tao Zhang; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

Review 3.  Neuropathology in chronic traumatic encephalopathy: a systematic review of comparative post-mortem histology literature.

Authors:  Helen C Murray; Chelsie Osterman; Paige Bell; Luca Vinnell; Maurice A Curtis
Journal:  Acta Neuropathol Commun       Date:  2022-08-06       Impact factor: 7.578

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.